On 17 November 2020, the Turkish Medicines and Medical Devices Agency announced (Turkish language) that physical promotional materials could be provided during visits to physicians...

On 20 March 2020, the Turkish Medicines and Medical Devices Agency published an announcement (Turkish language) titled "Precautions to be Taken in Clinical Research Due to COVID-19 Pandemic".

As per the Presidential Decree 3592, published in the Official Gazette (31418) dated 09 March 2021, the termination ban and unilateral unpaid leave have been extended for a further two months...

Mehmet Gün gave an interview to InterContinental Finance & Law Magazine about our firm and his role in the firm as the founder.

On 20 April 2023, significant changes were made to the regulations regarding the use of health claims on food and dietary supplements.

Following the structural changes introduced in 2023 to the regulatory framework governing health claims on food and dietary supplements, the subsequent period has been characterised less by new legislative...

The announcement clarifies the status of certified documents, product registration and movement requirements relating to medical devices in the context of the transition to the Regulation.

Reminding everyone of the critical role that intellectual property plays in encouraging creativity and innovation, we will discuss the top patent cases of 2020 in Turkey and UK perspective and case law about the same.

Prof. Rana Sanyal is just the right person to celebrate the "can do" attitude of women inventors in Turkey. Prof. Sanyal will be our guest in our webinar to tell us about her journey in her ground-breaking work.

İlaç şirketleri tarafından gerçekleştirilen değer aktarımlarına ilişkin hiçbir kamuya ifşa kuralı bulunmamaktadır. Bununla birlikte

There is no public disclosure rule for value transfers made by pharmaceutical companies. However, according to the Regulation on the Promotional Activities of Pharmaceutical Products for Human Use ("Promotion Regulation")...

There is no public disclosure rule for value transfers made by pharmaceutical companies. However, according to the Regulation on the Promotional Activities of Pharmaceutical Products for Human Use...

Access to vaccine and patent rights have never been more important and debatable.

The Turkish Medicines and Medical Devices Agency's guidelines on the Named Patient Programme (Turkish language) explains the procedure for the supply from abroad of drugs that are not authorised in ...

Life sciences companies in Türkiye operate within a well-established regulatory framework governing interactions with healthcare professionals, where promotional activities face strict limitations and transparency requirements.

On 12 February 2021, the Turkish Medicines and Medical Devices Agency published new guidelines (Turkish language) for the implementation of regulation on sales

Through Circular numbered 2016/4 published by the Turkish Medicines and Medical Device Agency ("TITCK") an obligation for marketing authorization holders to apply to TITCK.

In the early stages of pandemic, the time limits, including the ones before the Office, were suspended from March 13, 2020 until June 15, 2020.

The Advertisement Board rendered a guiding decision in September 2022 with respect to the advertisements published by an international fashion company operating in Turkey...

A global legal compendium of the laws related to privacy law and data protection relating to advertising and marketing in 70 countries around the globe. Written by members of the Global....